stockrow
Friday 6 November 2026
Export PLYX’s income statement to Excel — free account
Polaryx Therapeutics, Inc.
PLYX Healthcare Biotechnology
1.80
0.00
0.00%
Follow PLYX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+2 more TTM periods Free account |
|
| (169.05%) | 0.00% | — | — | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(91.27%) | 0.00% | 0.00% | — | |
Free Cash Flow per Share |
(0.17) | (0.16) | 0.00 | 0.00 | |
Free Cash Flow |
(8.23) | (7.57) | (8.08) | — | |
| Other line items | |||||
Cash ROIC |
(36.63%) | (136.03%) | (83.27%) | 0.00% | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | — | — | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Operating CF/Net income |
0.82 | 0.00 | 0.00 | — | |
Revenue per Share |
0.00 | 0.00 | — | 0.00 | |
Operating CF per Share |
(0.17) | (0.16) | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | — | 0.00 |
Columns are period end dates